Abstract. Phosphoinositol (PhoIns)-specific phospholipase C enzymes (PLCs) are central to the inositol lipid signaling pathways and contribute to intracellular Ca 2+ release and protein kinase C activation. Five distinct classes of PhoInsspecific PLCs are known to exist in mammals, which are activated by membrane receptor-mediated events. Here we have identified a sixth class of PhoIns-specific PLC with a novel domain structure, which we have termed PLC-Ë. Two putative PLC-Ë enzymes were identified in humans and in mice. Sequence analysis revealed that residues implicated in substrate binding and catalysis from other PhoIns-specific PLCs are conserved in the novel enzymes. PLC-Ë enzymes are most closely related to the PLC-‰ class and share a close evolutionary relationship with other PLC isozymes. EST analysis and RT-PCR data suggest that PLC-Ë enzymes are expressed in several cell types and, by analogy with other mammalian PhoIns-specific PLCs, are likely to be involved in signal transduction pathways.
Introduction
Phospholipase C enzymes (PLCs, EC 3.1.4.3) catalyze the cleavage of membrane phospholipids to 1,2-diacylglycerol (DAG) and their respective phosphoryl compound. In mammals, five distinct classes of PLCs have previously been identified (ß, Á, ‰, Â and ˙), all of which specifically react with phosphoinositols (PhoIns) (1) (2) (3) . PLC-cleavage of phosphatidylinositol (PtdIns) 4,5-bisphosphate results in the generation of DAG and inositol 1,4,5-triphosphate, which promote the activation of protein kinase C and the release of Ca 2+ from intracellular stores, respectively (4, 5) . The five known classes of mammalian PLCs contain several conserved domains, which include Pleckstrin homology (PH), EF-hand, catalytic X and Y and C2 domains. The enzymes have been classified on the basis of amino acid sequence and by the mechanisms they activate in response to ligand interactions with various receptors.
PLC-ß isozymes are activated by the action of G proteins associated with plasma and nuclear membranes (6) . G proteins consist of ·, ß and Á subunits that are stably bound in the inactive, GDP-bound state. Interface between the G protein and an agonist-occupied receptor triggers the exchange of GDP for GTP on the · subunit and its dissociation from the ß and Á subunits. Both the G· subunit and GßÁ dimer activate PLC-ß (7, 8) . PLC-Á isozymes are activated by the action of a range of receptor protein tyrosine kinases, which autophosphorylate upon binding of various growth factors (9) . These phosphorylation sites then function as docking sites for PLC-Á (10). The mechanisms of PLC-‰ activation remain poorly understood. PLC-‰ isozymes are more sensitive to Ca 2+ than other isozymes and may therefore be sufficient to trigger their activation (1) . Another potential regulator of PLC-‰ enzymes is a recently discovered high-molecular-weight G protein (11) . This protein forms a complex with PLC-‰1 in cells stimulated through · 1 -adrenergic or oxytocin receptors (11, 12) . The PLC-Â isozymes are involved in Ras signaling. The Ras family of enzymes is a group of GTPases that regulate pathways involved in cell proliferation, differentiation and apoptosis (13) . Expression of wild-type PLC-Â has been shown to promote the generation of the GTP-bound form of Ras in cultured cells (14, 15) . The last known member of the mammalian PLC family, PLC-˙, has been identified as the main trigger of Ca 2+ oscillations at the very first stage of development, when sperm meets egg (2) . PLC-‰1 also induces Ca 2+ oscillations in eggs, albeit less efficiently than PLC-(~2 0-fold higher concentration of PLC-‰1 is required) (16) . This suggests that PLC-˙may be activated by a similar mechanism to PLC-‰ isozymes.
PLCs that show specificity toward membrane phospholipids other than PtdIns are present in bacteria (17) and are thought to also exist in mammals. A role in mammalian signal transduction for a phosphocholine (PhoCho)-specific PLC has previously been described (18, 19) . These studies suggest the existence of other mammalian PLC enzymes. Whilst searching for a mammalian PhoCho-specific PLC, two new PhoIns-specific PLC enzymes were identified. These enzymes, which we have named PLC-Ë1 and PLC-Ë2, are described here.
Materials and methods
Database and sequence analysis. Searches were performed using the Ensembl Genome Browser available from the EMBL and Sanger Institute and with the tBLASTn algorithm (NCBI) (20) using short stretches of sequence (20-30 amino acids) from phosphatidylcholine-specific PLC from Pseudomonas fluorescens (accession no. AJ304443) (17) . The Pfam database (available from the Sanger Institute) (21) was used to search for conserved PLC-associated domains in resultant sequences.
Phylogenic analysis. Initial multiple alignments of protein sequences were carried out using the EMBOSS program, EMMA (available from http://www.hgmp.mrc.ac.uk/ Registered/Option/emboss.html). A phylogenic tree was then created from an aligned region (between 141 and 148 amino acids long) using PHYLIP v3.6 (http://evolution.genetics. washington.edu/phylip.html). One hundred bootstrap replicates were initially used to run the analysis. The JonesTaylor-Thornton matrix (22) was then applied to the 100 datasets. A consensus of these datasets was found to give a statistically significant tree with bootstrap values by the Neighbour Joining method (23) . The following sequences were used (the hs-and mm-prefixes indicate human and murine forms of the proteins, respectively; accession numbers are shown in parentheses): hsPLC-ß1 (Q9NQ66), mmPLC-ß1 (Q9Z1B3), hsPLC-ß2 (NP_04564), hsPLC-ß3 (NP_000923), mmPLC-ß3 (NP_032900), hsPLC-ß4 (NP_000924), mmPLC-ß4 (NP_038857), hsPLC-Á1 (NP_002651), mmPLC-Á1 (AAH65091), hsPLC-Á2 (P16885), mmPLC-Á2 (NP_758489), hsPLC-‰1 (Q8RB31), mmPLC-‰1 (Q8R3B1), hsPLC-‰3 (NP_588614), mmPLC-‰3 (NP_690023), hsPLC-‰4 (NP_116115), mmPLC-‰4 (NP_683739), hsPLC-Â, 2303 amino acids form (AAG17145), hsPLC-Â, 1994 amino acids form (AAG28341), mmPLC-Â (NP_062534), hsPLC-( NP_149114), mmPLC-˙(NP_473407), hsPLC-Ë1 (XP_042635), mmPLC-Ë1 (ENSMUSP00000047693; mouse NCBIm32), hsPLC-Ë2 (XP_371214), mmPLC-Ë2 (ENSMUSP 00000030929; mouse NCBIm30), hsPLC-‰1 (P51178).
Semi-quantitative RT-PCR.
Total RNAs were extracted from various tissues of male DF1 mice, aged 3-4 weeks, by phenol/chloroform extraction and treated with DNase I (Ambion) according to the manufacturer's instructions. The RT-PCR reaction was carried out using the Qiagen one-step RT-PCR kit. Primer pairs for 18S RNA were used as a control. The reaction mixture contained 100 ng RNA (25 ng was used with 18S RNA primers), 0.6 µM primer pairs and 400 µM dNTPs. The oligonucleotide primers used were PLC-Ë1: 5'-GAAAGATGCATGAGTGTAATGC-3' and 5'-CTGAAACATTTGCCTGACTTTTC-3'; PLC-Ë2: 5'-CCATCGACTCCATCCAGG-3' and 5'-TCCAGAAAGCGC TGCAGG-3'. These primers sets were designed to span at least one intron so that any amplification from contaminating genomic DNA would be identified. Oligonucleotide primers for 18S RNA were obtained from Ambion. The tissue RNAs were reverse transcribed for 30 min at 50˚C, then murine PLC-Ë1 and PLC-Ë2 transcripts were amplified using the cycling profile: 30 sec at 94˚C (1st cycle 15 min at 95˚C); 30 sec at 57˚C; 1 min at 72˚C with 30 cycles. Each reaction (12 µl) was analyzed on 1.5% agarose gels run in the presence of ethidium bromide (250 µg/l).
Results and Discussion
Identification of novel PLC enzymes. A search of the human EST database (NCBI) with sequence segments from PhoChospecific PLC from Pseudomonas fluorescens identified two novel genes encoding predicted PhoIns-specific PLCs. The corresponding proteins share 74% homology and are most closely related to the PLC-‰ class of enzymes, with which they share ~35% identity. A search within the Pfam database revealed that both enzymes have a novel domain structure containing PH, EF-hand, catalytic X and Y and C2 domains. The two novel enzymes were named PLC-Ë1 and PLC-Ë2 in accordance with current nomenclature. Fig. 1 shows the domain organization within all known mammalian PhoInsspecific PLC isozymes.
The PH domain (absent in PLC-˙) is a module found in many signaling proteins that binds to polyphosphoinositides (24) and indeed, many proteins that contain this domain associate with phospholipid membranes (25, 26) . However, it has recently been shown that the PH domain of PLC-‰4 is not essential for membrane localization (27) . The C-terminal regions of several PH domains bind to the ßÁ subunits of G proteins (28, 29) . The role of the EF-hand domain in PLCs is unclear, but appears to serve as a flexible link between the PH and the catalytic domains (30) . The active site in PLCs consists of both X and Y domains and requires Ca 2+ for catalytic function. The X domain is involved in both substrate and Ca 2+ binding, while the Y domain primarily interacts with the substrate (30) . It is these regions that contain the highest degree of sequence similarity among different mammalian PLCs (31) . The C2 domain is essential for catalytic activity (32) and often associated with proteins that interact with phospholipids. In some PLCs, the C2 domain binds Ca 2+ and mediates Ca 2+ -dependent interactions with the lipid membrane. It has been speculated that the C2 domain of PLC-‰1 may contain as many as four Ca 2+ -binding sites (32). The presence of these sequence motifs in PLC-Ë enzymes suggests they may also be involved in signal transduction. In addition to these domains, several PLC isozymes contain other sequence motifs that contribute to their activation. PLC-Á isozymes contain SH2 and SH3 domains between the catalytic X and Y domains, which facilitate their interaction with receptor tyrosine kinases (10) . Whilst PLC-Â isozymes contain RasGEF and RA domains at their N-and C-terminal ends, respectively (1).
The genes encoding human PLC-Ë1 and PLC-Ë2 are located on chr.3q25.31 and chr.1p36.32, respectively. Orthologuous proteins were also identified in mice, although it was found that the murine PLC-Ë1 mRNA sequence corresponds to a protein that is ~350 residues longer at the C-terminal end than its human equivalent. Partial sequences that also appear to be orthologous were found in other species including rat, zebrafish (Danio rerio), puffer fish (Takifugu rubripes) and nematode worm (Caenorhabditis elegans) (data not shown).
The putative PLC-Ë enzymes. Analysis of the full-length human transcripts using the web-based program, SignalP v1.1 (33) , predicts the absence of a signal peptide in either protein. This suggests that both proteins are soluble cytoplasmic enzymes. Sequence comparison between PLC-Ë1, PLC-Ë2 and PLC-‰s reveal significant differences. A sequence alignment of human and murine PLC-Ë isozymes with human PLC-‰1 is shown in Fig. 2 . The region between the X and Y catalytic domains is ~100 residues longer in PLC-Ë enzymes. Also, the human PLC-Ë isozymes contain an additional Cterminal region that is particularly rich in serine and proline residues. Serine-and proline-rich regions have been found in many transcription factors and have a proposed role in proteinprotein interactions (34, 35) . This region may therefore have functional importance in these enzymes.
The X-ray crystal structure of rat PLC-‰1 in the presence of bound calcium and inositol 1,4,5-triphosphate reveal that residues His311, Asn312, Glu341, Asp343, and Glu390 coordinate to the catalytic Ca 2+ ion. In addition, Lys438, Lys440, Ser522, Arg549 and Tyr551 are shown to specifically interact with inositol 1,4,5-triphosphate (12) . This is supported by mutational analysis, which confirm that Asn312, Glu341, Asp343 and Glu390 contribute toward Ca 2+ -binding and demonstrate Lys438, Ser522 and Arg549 to be important for the preferential hydrolysis of polyphosphoinositides (36) . All of the aforementioned PLC-‰1 residues known to be involved in substrate binding and catalysis are completely conserved within the catalytic X and Y domains of PLC-Ë1 and PLC-Ë2 ( Fig. 2) . As a result, it is very likely that the PLC-Ë enzymes also function as PhoIns-specific phospholipases in vivo.
The Ca 2+ -mediated lipid-binding site in the C2 domain of synaptotagmin I consists of four aspartate residues, Asp172, Asp178, Asp230 and Asp232 (37) . All four of these residues are conserved in the PLC-Ë enzymes, but not in PLC-‰1 where Asp172 is equivalent to Asn645 (12) . This suggests that Ca 2+ ions bind more tightly at this site to synaptotagmin I and to the PLC-Ë enzymes than to PLC-‰1. Additionally, it indicates that PLC-Ë enzymes, like other PLCs, interact with membrane lipids following Ca 2+ binding at this region. Other groups of PhoIns-specific PLCs such as the PLC-ß and PLC-Á enzymes also contain a C2 domain, yet key residues involved in Ca 2+ binding are not conserved (3) . This is a similar situation to that observed within some protein kinase C and synaptotagmin subtypes whose C2 domains are also unable to bind calcium. It has been speculated that within these enzymes the function of the C2 domain is to recognize other regulatory lipids or proteins. For example, the C2 domain of PLC-ß1 has been found to bind specifically to GTP-charged · q , its physiological activator (38) .
Phylogenic analysis performed with human and murine PLC-Ë1 and PLC-Ë2 protein sequences reveal that a close evolutionary relationship exists between these and other PhoIns-specific PLC enzymes. Fig. 3 shows a rooted phylogenic tree of human and murine PLCs with bootstrap values inserted at each branch node. The tree reveals that PLC-Ë isozymes lie closest to the root and supports the classification of these novel enzymes into a new group. PtdIns-specific PLC-Ë enzymes are consequently likely to have formed at an earlier point during evolution than the other PLCs and may exist in a wider range of species.
Tissue distribution of PLC-Ë enzymes. At present, ESTs available in dbEST at the NCBI server indicate that the gene encoding human PLC-Ë1 is expressed in colon, embryonic stem cells, retinoblastoma and teratocarcinoma cells. ESTs corresponding to human PLC-Ë2 were identified in cDNAs isolated from anaplastic oligodendroglioma, epithelioid carcinoma, leukopheresis, lymph, nerve tumor, optic nerve, pancreatic islet, pituitary and retinoblastoma cell populations. Murine ESTs corresponding to PLC-Ë1 were found in cDNAs isolated from brain, eye, kidney, neural retina and upper head. The murine PLC-Ë2 sequence matched ESTs from brain. RT-PCR analysis of RNA isolated from a range of murine tissues revealed bands of expected size corresponding to the expression of both PLC-Ë enzymes in the brain and gut (Fig. 4) . The observed expression of both enzymes in the brain by RT-PCR is in agreement with the EST data. No detectable expression was observed in the other tissues assayed.
By analogy with other PhoIns-specific PLCs, these data suggest that the PLC-Ë enzymes may function in the membrane-mediated signaling cascade through intracellular Ca 2+ and protein kinase C pathways in several different cell types. Such pathways are crucial for the initiation of cellular processes including proliferation, differentiation and apoptosis. The discovery of these enzymes is therefore important and is expected to trigger further research towards their cellular function. Primers corresponding to 18S RNA were used as a control. The expression of both PLC-Ë1 and PLC-Ë2 enzymes was observed in the brain and gut.
